Table 5.
Whey permeate1, % | P-value | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Item | 0 | 3.75 | 7.50 | 11.25 | 15.00 | 18.75 | SEM | Linear | Quad. | 0% vs. others |
Histomorphology | ||||||||||
Villus height, μm | 548 | 531 | 571 | 531 | 547 | 500 | 32 | 0.359 | 0.391 | 0.701 |
Villus width2, μm | 98 | 98 | 99 | 100 | 95 | 105 | 4 | 0.483 | 0.747 | 0.377 |
Crypt depth, μm | 268 | 255 | 265 | 253 | 247 | 251 | 8 | 0.082 | 0.725 | 0.121 |
VH:CD | 2.04 | 2.08 | 2.15 | 2.11 | 2.23 | 1.99 | 0.12 | 0.868 | 0.256 | 0.569 |
Crypt cell proliferation, % | 27.8 | 29.1 | 31.8 | 31.6 | 34.2 | 37.0 | 3.0 | 0.012 | 0.762 | 0.113 |
Immune response | ||||||||||
TNF-α, pg/mg | 0.80 | 0.81 | 0.72 | 0.72 | 0.74 | 0.91 | 0.16 | 0.359 | 0.754 | 0.924 |
IL-8, pg/mg | 170 | 214 | 223 | 203 | 214 | 202 | 14 | 0.272 | 0.052 | 0.015 |
TGF-β1, pg/mg | 4.40 | 3.10 | 3.88 | 3.64 | 4.18 | 2.86 | 0.75 | 0.387 | 0.857 | 0.225 |
MUC2, U/mg | 0.52 | 0.43 | 0.43 | 0.55 | 0.53 | 0.39 | 0.07 | 0.700 | 0.656 | 0.456 |
Digestive enzyme activity | ||||||||||
Sucrase, U/mg | 20.4 | 21.4 | 19.1 | 16.5 | 20.7 | 18.8 | 2.0 | 0.413 | 0.514 | 0.587 |
Maltase, U/mg | 87.1 | 70.4 | 56.5 | 46.8 | 92.4 | 51.4 | 12.3 | 0.222 | 0.288 | 0.077 |
Lactase, U/mg | 15.8 | 11.7 | 9.0 | 9.3 | 4.9 | 6.6 | 2.8 | 0.020 | 0.441 | 0.033 |
1Treatments were the supplemental levels of whey permeate in the diets.
2Villus width is the average of the three lengths (tip, middle, and base of villus).